Article
An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: Results of a large-scaled and controlled study

https://doi.org/10.1016/0306-4530(93)90037-LGet rights and content

Abstract

In order to evaluate the function of the hypothalamic-pituitary-thyroid (HPT)-axis in unipolar depression, the authors measured basal 0800h plasma levels of free thyroxine (FT4), free triiodothyronine (FT3), and thyroid stimulating hormone (TSH) by means of the new, ultrasensitive assays (TSH-IRMA) in 69 healthy controls, 62 minor, 101 simple major, and 57 melancholic depressed subjects. Basal HPT-axis hormone levels of almost all (96.8%) unipolar depressed patients fell within the normal, euthyroid range. None of the major depressed subjects showed subclinical hypothyroidism. It was found that 8.8% of the melancholic subjects exhibited some degree of subclinical hyperthyroidism. Basal TSH-IRMA values were significantly lower in melancholic patients than in healthy controls, minor and simple major depressed patients, and in major vs. minor depressed subjects. FT4 circulating levels were significantly higher in melancholic patients than in all other subjects. Basal TSH-IRMA and FT4 levels were significantly correlated with severity of illness. In depression, there was a significant and negative correlation between basal TSH-IRMA values and FT4 concentrations. No significant gender- or age-related differences in TSH-IRMA or thyroid hormones were detected in depression. It is argued that—in depression research—the assays of basal TSH-IRMA should replace thyrotropin releasing hormone tests.

References (56)

  • M Maes et al.

    Clinical subtypes of unipolar depression, part III: Quantitative differences in various biological markers between the cluster analysis-generated nonvital and vital depression classes

    Psychiatry Res

    (1990)
  • M Maes et al.

    Higher α1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: Further evidence for the existence of an inflammatory response during that illness

    J Affect Disord

    (1992)
  • M Maes et al.

    A revised interpretation of the TRH test results in female depressed patients. Part I: TSH responses

  • M Maes et al.

    Anthropometric and biochemical assessment of the nutritional state in depression: Evidence for lower visceral protein plasma levels in depression

    J Affect Disord

    (1991)
  • M Maes et al.

    Suppressive effects of dexamethasone on hypothalamic-pituitary-thyroid axis function in depressed patients

    J Affect Disord

    (1990)
  • SE Molchan et al.

    The TRH stimulation test in Alzheimer's disease and major depression: Relationship to clinical and CSF measures

    Biol Psychiatry

    (1991)
  • D Mossman et al.

    Assessing improvements in the Dexamethasone Suppression Test using receiver operating characteristic analysis

    Biol Psychiatry

    (1989)
  • AJ Prange et al.

    Effects of thyrotropin-releasing-hormone in depression

    Lancet

    (1972)
  • SD Targum et al.

    The TRH stimulation test in subtypes of unipolar depression

    J Affect Disord

    (1982)
  • S Wilk

    Prolyl endopeptidase

    Life Sci

    (1983)
  • American Psychiatric Association

    Diagnostic and Statistical Manual of Mental Disorders

    (1980)
  • A Baumgartner et al.

    The hypothalamic-pituitary-thyroid axis in psychiatric patients and healthy subjects: Parts 1–4

    Psychiatry Res

    (1988)
  • P Blockx et al.

    Comparison by receiver operating characteristics (ROC) analysis of three thyrotropin assays in the diagnosis of hyperthyroidism

  • IG Bottger et al.

    TSH response to TRH as a function of basal serum TSH—New aspects in pituitary-thyroid regulation

  • AG Burger et al.

    Starvation induces a partial failure of triiodothyronine to inhibit the thyrotropin response to thyrotropin releasing hormone

    J Clin Endocrinol Metabol

    (1980)
  • KL Cohen et al.

    Thyroid function screening in psychiatric patients

    JAMA

    (1979)
  • WR Dillon et al.

    Linear Structural Relations (Lisrel)

  • F Duval et al.

    Difference between evening and morning thyrotropin response to protirelin in major depressive episode

    Arch Gen Psychiatry

    (1990)
  • Cited by (68)

    • Sexual function and depressive symptoms in young women with overt hyperthyroidism

      2019, European Journal of Obstetrics and Gynecology and Reproductive Biology
    • Expression levels of interferon-ɣ and type 2 deiodinase in patients diagnosed with recurrent depressive disorders

      2018, Pharmacological Reports
      Citation Excerpt :

      Depressive disorder is a disease with multifactorial components, including disturbances in the hypothalamic-pituitary-thyroid (HPT) axis and TH concentration, the presence of immune activation and inflammation [14–16]. Depressed patients are characterized by TRH-mRNA downregulation, elevated peripheral free T4 levels [17,18], and increased rT3 concentrations in CSF [19], but not in serum [20]. In addition, hyper- and hypothyroid states are often observed in depressed patients, may be involved and in the development of a depressive disorder.

    • Polymorphisms of iodothyronine deiodinases (DIO1, DIO3) genes are not associated with recurrent depressive disorder

      2016, Pharmacological Reports
      Citation Excerpt :

      For example, sera thyroxine (T4) levels and cerebrospinal fluid reverse triiodothyronine (rT3) concentration [4,5] are found to be increased, while basal thyroid secreting hormone (TSH) levels are decreased and associated with increased free T4 (FT4) levels [3–5]. In a large-scaled study, both increases in FT4 and lowered TSH levels were associated with severity of depression [3]. Studies in animal models revealed that antidepressants may increase triiodothyronine [T3] brain levels [6].

    • Relationship between thyroid-stimulating hormone levels and risk of depression among the general population with normal free T4 levels

      2015, Psychoneuroendocrinology
      Citation Excerpt :

      Interestingly, in a cross-sectional analysis of general population, lower TSH and higher T4 levels were associated with current depression in young adults and elderly people (Forman-Hoffman and Philibert, 2006; Medici et al., 2014), although no association in adults aged 50 to 70 years has been reported. In several clinical studies, hyperactivity of the HPT axis was observed in depressive patients, and thyroxine levels decreased with treatment (Maes et al., 1993). Meanwhile, low normal thyroid function was associated with poorer treatment response and with lower rate of remission in depressive patients (Abulseoud et al., 2013; Cole et al., 2002) Collectively, previous findings are consistent with the hypothesis that hyperactivity of the HPT axis in a depressive state may represent a compensatory homeostatic response of the central nervous system to the depressive state (Whybrow and Prange, 1981) and that failure of such response, indicated by high TSH or low free T4 levels, is related to depressive recurrence as well as negative prognosis.

    View all citing articles on Scopus
    View full text